VASO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VASO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Vaso's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 105.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Vaso's 3-Year ROIIC % or its related term are showing as below:
The historical data trend for Vaso's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaso Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
3-Year ROIIC % | Get a 7-Day Free Trial | -13.16 | -115.27 | -80.66 | 378.30 | 105.91 |
Vaso Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
3-Year ROIIC % | Get a 7-Day Free Trial | - | 105.91 | - | - | - |
For the Health Information Services subindustry, Vaso's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Vaso's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Vaso's 3-Year ROIIC % falls into.
Vaso's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
3-Year ROIIC % | = | 3-Year Incremental Net Operating Profit After Taxes (NOPAT)** | / | 3-Year Incremental Invested Capital** |
= | ( 4.109422 (Dec. 2023) - 0.7741616 (Dec. 2020) ) | / | ( 52.773 (Dec. 2023) - 49.624 (Dec. 2020) ) | |
= | 3.3352604 | / | 3.149 | |
= | 105.91%*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Vaso (OTCPK:VASO) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Thank you for viewing the detailed overview of Vaso's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Jun Ma | director | C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590 |
Leon Dembo | director | 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803 |
Janey Moen | director | 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803 |
Edgar Rios | director | 1650 TYSONS BOULEVARD, SUITE 900, MCLEAN VA 22102 |
Michael Beecher | officer: Chief Financial Officer | C/O DIRECT INSITE CORP, 80 ORVILLE DRIVE, BOHEMIA NY 11716 |
Joshua Markowitz | director | 3131 PRINCETON PIKE, BLDG. 3D, SUITE 200, LAWRENCEVILLE NJ 08648 |
Jonathan P Newton | officer: Vice Pres Finance & Controller | 152 RICHMOND AVENUE, AMITYVILLE NY 11701 |
Peter C Castle | director | C/O NETWOLVES CORP, 4002 EISENHOWER BLVD, TEMPA FL 33634 |
David H Lieberman | director | 3061 INDUSTRY DR, LANCASTER PA 17603 |
Behnam Movaseghi | director | C/O KERNS MANUFACTURING CORPORATION, 37-14 29TH STREET, LONG ISLAND CITY NY 11101 |
Nelson Randall Hill | officer: Senior Vice President | 3880 EAST COUNTY HIGHWAY 30A, UNIT 201, SANTA ROSA BEACH FL 24159 |
William Edward Dempsey | director | 52 PARK AVENUE, SANDYMOUNT L2 DUBLIN 4 |
David Tarachand Singh | officer: Chief Financial Officer | C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590 |
Joseph Giacalone | director | |
Derek Enlander | director | 88C UNION AVENUE, CENTER MORICHES NY 11934 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 06-25-2021
By ACCESSWIRE ACCESSWIRE • 08-15-2022
By ACCESSWIRE AccessWire • 04-12-2019
By [email protected] [email protected] • 06-04-2020
By ACCESSWIRE ACCESSWIRE • 08-14-2020
By ACCESSWIRE AccessWire • 04-15-2019
By Kyle Ferguson Kyle Ferguson • 11-16-2016
By ACCESSWIRE ACCESSWIRE • 11-13-2020
By ACCESSWIRE ACCESSWIRE • 05-05-2021
By ACCESSWIRE • 08-14-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.